---
schema_version: "secwatch.filing_event.v1"
accession: "0001759425-24-000023"
form_type: "8-K"
ticker: "MIRM"
cik: "0001759425"
company_name: "Mirum Pharmaceuticals, Inc."
filed_at: "2024-06-06T23:59:59+00:00"
generated_at: "2026-06-01T05:57:34.250183+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Stockholders elect all three Class II directors, ratify auditor, approve say-on-pay, set frequency to one year

## Summary
- Elected Laurent Fischer, Patrick Heron, and Saira Ramasastry as Class II directors (each received >19M votes for).
- Ratified Ernst & Young as independent auditor for FY2024 (37.5M for, 36k against, 143k abstain).
- Advisory approval of executive compensation: 32.7M for, 1.1M against, 90k abstain.
- Advisory vote on say-on-pay frequency: 33.8M for one year; board adopts annual frequency.

## SEC filing metadata
- accession: 0001759425-24-000023
- form_type: 8-K
- ticker: MIRM
- cik: 0001759425
- company_name: Mirum Pharmaceuticals, Inc.
- filed_at: 2024-06-06T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1759425/000175942524000023/0001759425-24-000023-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1759425/000175942524000023/mirm-20240605.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001759425-24-000023
- JSON: https://secwatch.observer/filing/0001759425-24-000023.json
- Plain text: https://secwatch.observer/filing/0001759425-24-000023.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.